Zealand's Dutch leading investor looks forward to two hectic years: "There are more triggers"

Head of Investments for the Dutch family foundation Van Herk, Dharminder Chahal, is looking forward to getting certainty over a number of central points in Zealand Pharma's business plan over the next two years, where the company reaches several milestones.

Dharminder Chahal is head of investments at the Dutch family foundation Van Herk's investment arm, and is behind the foundations investment in Zealand Pharma. Photo: Exponential / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles